Allergy drug improves function in patients with chronic injury from multiple sclerosis

In a remarkably rapid translation of laboratory research findings into a treatment with the potential to benefit patients, UC San Francisco scientists have successfully completed a Phase II clinical trial showing that an FDA-approved antihistamine restores nervous system function in patients with chronic multiple sclerosis (MS).
Source: World Pharma News - Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news